
Cardiovascular Systems CSII
Quarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Operating Cycle 2011-2025 | CSII
Annual Operating Cycle Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 254 | 225 | 219 | 191 | 206 | 207 | 227 | 191 | 209 | 145 | 194 | 192 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 254 | 145 | 205 |
Quarterly Operating Cycle Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 255 | 259 | 115 | 256 | 219 | 268 | 122 | 263 | 247 | 248 | 210 | 220 | 183 | 185 | 168 | 183 | 196 | 200 | 179 | 195 | 213 | 219 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 268 | 115 | 209 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
232 | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Apyx Medical Corporation
APYX
|
299 | $ 3.86 | -3.26 % | $ 134 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
304 | $ 308.13 | - | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
170 | $ 0.92 | - | $ 14.8 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
793 | $ 17.6 | - | $ 406 M | ||
|
Bruker Corporation
BRKR
|
274 | $ 45.13 | - | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
183 | $ 125.46 | - | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
184 | $ 92.58 | - | $ 136 B | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
200 | $ 62.75 | - | $ 3.4 B | ||
|
LENSAR
LNSR
|
213 | $ 11.51 | - | $ 133 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 2.88 | - | $ 107 M | ||
|
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
Orthofix Medical
OFIX
|
356 | $ 15.49 | - | $ 591 M | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
PAVmed
PAVM
|
16.8 | $ 0.33 | - | $ 2.39 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 9.86 | - | $ 708 M | ||
|
Quanterix Corporation
QTRX
|
204 | $ 7.56 | - | $ 284 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
InMode Ltd.
INMD
|
246 | $ 14.51 | - | $ 1.15 B | ||
|
Align Technology
ALGN
|
171 | $ 165.43 | - | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
233 | $ 1.06 | - | $ 109 M | ||
|
IRadimed Corporation
IRMD
|
308 | $ 96.23 | -1.18 % | $ 1.22 B | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
266 | $ 12.71 | - | $ 344 M | ||
|
FONAR Corporation
FONR
|
251 | $ 14.75 | - | $ 96.7 M | ||
|
AxoGen
AXGN
|
274 | $ 30.39 | - | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
278 | $ 40.83 | - | $ 1.26 B | ||
|
Sensus Healthcare
SRTS
|
363 | $ 3.83 | -1.54 % | $ 62.5 M | ||
|
STRATA Skin Sciences
SSKN
|
154 | $ 1.42 | - | $ 49.3 M |